SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 7 — Focused Visit (Care-plan review) — Frederick Cook

PatientFrederick Cook
Date of birth1961-06-10
IdentifiersMRN HR-EX006-SYN; SSN (made up) 000-06-4471
Document date2026-10-27
AuthorHarriet Okafor-Brandt, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Sixteen-week review of blood pressure, potassium and kidney function four weeks after starting losartan; mood and stroke prevention. [S]

History of Present Illness

Mr. Cook returns four weeks after changing from hydrochlorothiazide to losartan 50 mg, with amlodipine 5 mg, atorvastatin 40 mg and aspirin 81 mg. He has no dizziness, cough or swelling, and no gout. His home readings average 124/76. He did not have the blood test that was meant to be done one to two weeks after starting losartan; it was drawn this morning. His prison medical records have arrived and record no earlier diagnoses or vaccinations. His fecal immunochemical test was negative. He feels more settled, is writing every morning, and still feels a sting of shame when he is recognized, though it troubles him less. He has had no stroke symptoms. [S]

ElementDetail
Home blood pressureAverage 124/76
Medicine effectsNo dizziness, cough or swelling; no gout
RecordsPrison records received; no earlier diagnoses or vaccinations recorded
ScreeningFecal immunochemical test negative
MoodMore settled; PHQ-9 4

Review of Systems

SystemResultFinding
CardiovascularNegativeNo chest pain or ankle swelling
RespiratoryNegativeNo cough
NeurologicalNegativeNo weakness, numbness, speech trouble, loss of vision, or dizziness
MusculoskeletalNegativeNo joint pain or muscle aches
PsychiatricNegativeMood better; no thoughts of self-harm

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Hydrochlorothiazide 25 mg tablet, one tablet by mouth each morningonce daily in the morningOral route2026-07-21 to 2026-09-29completedS
Amlodipine 5 mg tablet, one tablet by mouth dailyonce dailyOral route2026-07-21activeS
Atorvastatin 40 mg tablet, one tablet by mouth dailyonce dailyOral route2026-07-21activeS
Aspirin 81 mg delayed-release tablet, one tablet by mouth dailyonce dailyOral route2026-07-21activeS
Losartan 50 mg tablet, one tablet by mouth dailyonce dailyOral route2026-09-29activeS
Colchicine 0.6 mg tablet: two tablets at once, one more an hour later, then one tablet twice a day until the flare settles, for up to a week1.2 mg, then 0.6 mg an hour later, then 0.6 mg twice daily for up to a weekOral route2026-09-08 to 2026-09-13completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-10-27Body height175cmS
2026-10-27Body weight74.8kgS
2026-10-27Body mass index (BMI) [Ratio]24.4kg/m2S
2026-10-27Systolic blood pressure126mm[Hg]S
2026-10-27Diastolic blood pressure76mm[Hg]S
2026-10-27Heart rate66/minS
2026-10-27Respiratory rate14/minS
2026-10-27Body temperature36.6CelS
2026-10-27Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-27Sodium [Moles/volume] in Serum or Plasma139mmol/L136-145 mmol/LNormalS
2026-10-27Potassium [Moles/volume] in Serum or Plasma4.5mmol/L3.5-5.1 mmol/LNormalS
2026-10-27Creatinine [Mass/volume] in Serum or Plasma1.06mg/dL0.74-1.35 mg/dLNormalS
2026-10-27Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M78mL/min/{1.73_m2}60 or moreNormalS
2026-10-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S

Physical Exam

Vital signs recorded on 2026-10-27; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 126/76, pulse 66, weight 74.8 kg
NeckSoft right carotid bruit, unchanged
CardiovascularRegular rhythm; no ankle edema
PsychiatricBrighter; engaged and humorous

Problems

ProblemClinical statusVerificationCodeProvenance
Elevated blood pressure at the first visit, 166/94 mmHg (average of two seated readings), without a previous diagnosis of hypertension; no symptoms; out-of-office confirmation with a week of home readings requestedresolvedconfirmed R03.0S — Synthetic presenting finding at re-entry; superseded by the diagnosis at the second visit.
Essential hypertension, stage 2, confirmed by home readings averaging 154/90 mmHg; no left ventricular hypertrophy on ECG; urine albumin normalactiveconfirmed I10S — Synthetic modern diagnosis made at the second visit.
Right carotid bruit heard at the first visit in a man with no symptoms of stroke or transient ischemic attack; carotid duplex ultrasound and vascular neurology consultation requestedresolvedconfirmed R09.89S — Synthetic examination finding; superseded by the duplex result at the second visit.
Asymptomatic atherosclerotic stenosis of the right internal carotid artery, 50 to 69 percent by duplex ultrasound, with less than 50 percent plaque on the left; no stroke or transient ischemic attack; managed with best medical therapy (blood pressure control, a statin and low-dose aspirin) and yearly duplex surveillanceactiveconfirmed I65.21S — Synthetic modern diagnosis made at the vascular neurology consultation; not a claim about his real arteries.
Recent release from about six years of incarceration: re-entering community life on parole at 65, establishing primary care with no medical records yet received, a rented room, no earned income, and a public reputation he feels as a burdenactiveconfirmed Z65.2S — Synthetic modern social problem anchored to his documented imprisonment and parole.
Acute gout of the right first metatarsophalangeal joint, a first flare seven weeks after starting hydrochlorothiazide, diagnosed clinically (sudden overnight onset, redness, swelling and exquisite tenderness of the big toe, no fever); treated with low-dose colchicine; resolvedresolvedconfirmed M10.271S — Synthetic adverse drug effect; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationOffice blood pressure, seated, average of two readingsEvery visitCompleted today126/76 mmHg; at target
Self-managementHome blood pressure monitoringAt diagnosis and after each treatment changeCompleted todayAverage 124/76
LaboratorySodium, potassium, creatinine and eGFRBaseline; early after starting a diuretic or an ARB; then every 6 monthsCompleted todaySodium 139, potassium 4.5 mmol/L, creatinine 1.06 mg/dL, eGFR 78. Protocol deviation: the potassium and creatinine check ordered for one to two weeks after starting losartan was not drawn, because no date was booked and no visit fell in that window; it was drawn today, four weeks after starting. No harm resulted: potassium is normal and creatinine rose only 0.02 mg/dL. Corrective action: book the blood test with a date when a renin-angiotensin drug or a diuretic is started
LaboratoryLipid panelBaseline; 4 to 12 weeks after starting a statin; then every 3 to 12 monthsUp to dateLDL 68 mg/dL four weeks ago; next in 6 to 12 months
LaboratoryUrine albumin-to-creatinine ratioAnnuallyUp to date18 mg/g at intake; next due at the annual visit
LaboratoryHbA1c or fasting glucoseAnnuallyUp to dateHbA1c 5.5% at intake
Medication safetyARB effects: dizziness, potassium, creatinineEarly after starting, then every visitCompleted todayNo dizziness; potassium and creatinine normal
Medication safetyAntiplatelet adherence and bleedingEvery visitCompleted todayNo bleeding
Medication safetyStatin adherence and muscle symptomsEvery visitCompleted todayNo muscle symptoms
ImagingCarotid duplex ultrasound for known 50 percent or greater stenosis on medical therapyAt diagnosis, then yearlyUp to dateNext duplex due in about nine months
ExaminationPeripheral pulses and ankle-brachial indexEvery 2 to 3 years at 65 or olderDueAnkle-brachial index at the annual wellness visit
Self-managementStroke warning signs (BE FAST) and calling 911Every visitCompleted todayNo symptoms; knows the signs
SurveyDepression screen (PHQ-9)AnnuallyCompleted todayPHQ-9 4, from 7 at intake
Self-managementRe-entry social needs: housing, income, benefits, recordsEvery visit until settledCompleted todaySettled; records received

Goal progress:

Immunizations given today: Influenza vaccine, high-dose, trivalent; Recombinant zoster vaccine, dose 2 of 2 [S]

Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (Jones DW, et al. Hypertension 2025;82:e212-e316) (2025); CMID: Clinical Monitoring Intelligence Database, hypertension, hyperlipidemia and stroke/TIA monographs (2026); 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association (Bushnell C, et al. Stroke 2024;55:e344-e424) (2024); Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease (AbuRahma AF, et al. J Vasc Surg 2022;75(1S):4S-22S) (2021); 2018 AHA/ACC Guideline on the Management of Blood Cholesterol (Grundy SM, et al. Circulation 2019;139:e1082-e1143) (2018); Adult Immunization Schedule by Age (2026)

Follow-up: Review in three months, with home readings. Annual wellness visit next summer. Repeat carotid duplex in about nine months. [S]